» Articles » PMID: 38498260

Effect of Polyphenols Against Complications of COVID-19: Current Evidence and Potential Efficacy

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2024 Mar 18
PMID 38498260
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic that started in 2019 and resulted in significant morbidity and mortality continues to be a significant global health challenge, characterized by inflammation, oxidative stress, and immune system dysfunction.. Developing therapies for preventing or treating COVID-19 remains an important goal for pharmacology and drug development research. Polyphenols are effective against various viral infections and can be extracted and isolated from plants without losing their therapeutic potential. Researchers have developed methods for separating and isolating polyphenols from complex matrices. Polyphenols are effective in treating common viral infections, including COVID-19, and can also boost immunity. Polyphenolic-based antiviral medications can mitigate SARS-CoV-2 enzymes vital to virus replication and infection. Individual polyphenolic triterpenoids, flavonoids, anthraquinonoids, and tannins may also inhibit the SARS-CoV-2 protease. Polyphenol pharmacophore structures identified to date can explain their action and lead to the design of novel anti-COVID-19 compounds. Polyphenol-containing mixtures offer the advantages of a well-recognized safety profile with few known severe side effects. However, studies to date are limited, and further animal studies and randomized controlled trials are needed in future studies. The purpose of this study was to review and present the latest findings on the therapeutic impact of plant-derived polyphenols on COVID-19 infection and its complications. Exploring alternative approaches to traditional therapies could aid in developing novel drugs and remedies against coronavirus infection.

References
1.
Karimi Shahri M, Niazkar H, Rad F . COVID-19 and hematology findings based on the current evidences: A puzzle with many missing pieces. Int J Lab Hematol. 2020; 43(2):160-168. PMC: 7753300. DOI: 10.1111/ijlh.13412. View

2.
Salavati E, Hajirezaee H, Niazkar H, Ramezani M, Sargazi A . COVID-19 patients may present with myocarditis: A case report emphasizing the cardiac involvement of SARS-CoV-2. Med J Islam Repub Iran. 2021; 35:104. PMC: 8683805. DOI: 10.47176/mjiri.35.104. View

3.
Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff E, Chiang S . Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2020; 31(1):1-10. PMC: 7855377. DOI: 10.1002/rmv.2146. View

4.
Montenegro F, Unigarro L, Paredes G, Moya T, Romero A, Torres L . Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review. Expert Rev Respir Med. 2020; 15(2):183-195. DOI: 10.1080/17476348.2020.1820329. View

5.
Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q . Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS One. 2021; 16(5):e0250602. PMC: 8092779. DOI: 10.1371/journal.pone.0250602. View